2003
DOI: 10.1046/j.1365-2133.2003.05427.x
|View full text |Cite
|
Sign up to set email alerts
|

Pemphigoid gestationis: maternal sera recognize epitopes restricted to the N-terminal portion of the extracellular domain of BP180 not present on its shed ectodomain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
1
2

Year Published

2004
2004
2016
2016

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(16 citation statements)
references
References 9 publications
0
13
1
2
Order By: Relevance
“…The complement-binding test is a sensitive immunofluorescence assay used to detect complement-fixing autoantibodies to the DEJ in patients with immunobullous diseases. 24 Despite the presence of IgG3 autoantibodies staining the dermal side of the salt-split skin, circulating autoantibodies in the serum of our patient did not exhibit complementfixing properties. Our observation is in line with previous findings showing that the complementactivating capacity of EBA autoantibodies does not correlate with the inflammatory or noninflammatory type of the disease.…”
Section: Discussioncontrasting
confidence: 49%
“…The complement-binding test is a sensitive immunofluorescence assay used to detect complement-fixing autoantibodies to the DEJ in patients with immunobullous diseases. 24 Despite the presence of IgG3 autoantibodies staining the dermal side of the salt-split skin, circulating autoantibodies in the serum of our patient did not exhibit complementfixing properties. Our observation is in line with previous findings showing that the complementactivating capacity of EBA autoantibodies does not correlate with the inflammatory or noninflammatory type of the disease.…”
Section: Discussioncontrasting
confidence: 49%
“…Complementfixing activity of antibodies to the DEJ was determined as described (35). Briefly, sections of mouse and human skin were incubated with rabbit IgG and subsequently with fresh mouse serum as a source of complement.…”
Section: Methodsmentioning
confidence: 99%
“…14,15 This strong association indicates a pivotal role of MHC class II in the pathogenesis of the disease. 10 25 Another factor contributing to the emergence of PG is possibly an aberrant complement system, with 90% of PG patients carrying the C4 null allele (C4*QO), in contrast to 43% of controls. This may impair the removal of immune complexes and may facilitate their deposition; 26 however, the C4 allele is closely located at the DR alleles on chromosome 6, which consequently leaves a strong disequilibrium, complicating to discern the primary genetic link in PG relevant for disease pathogenesis.…”
Section: Pathogenesismentioning
confidence: 99%